Schedule 13G ownership disclosure
Paratek Pharmaceuticals Inc
Security class unavailable · CUSIP: 699374302
Event date: 2018-04-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,201,258
- Percent of class
- 6.5400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-18-002064
- Form type
- SC 13G
- Filer
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- CIK
- CIK 919185
- Filed
- Apr 30, 2018
- Reporting period
- Apr 23, 2018
- Description
- Schedule 13G beneficial ownership